Prof. Dr. Richard Greil
Head of the IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Prof. Peter Schmid FRCP MD PhD
Centre Lead, Centre for Experimental Cancer Medicine, Director, Breast Cancer, St Bartholomew, Hospital London, London, United Kingdom
Karen Willard-Gallo MD PhD
Head, Molecular Immunology Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
Prof. Alberto Mantovani MD
Humanitas University, Scientific Director, Istituto Clinico Humanitas IRCCS Milan, Italy
Prof. Dipl.-Ing. Dr. Zlatko Trajanoski
Biocenter, Division for Bioinformatics, Medical University of Innsbruck, Austria
Prof. Fabrice André MD PhD
Research Director, Head of INSERM, Unit U981, Institut Gustave Roussy, Department of Medical Oncology, Villejuif, France
Prof. Maria Rescigno PhD
Full Professor, Head, Mucosal Immunology and microbiota Unit, Humanitas University Milan, Italy
Prof. Richard Kennedy MD PhD (absent)
McClay Professor of Medical Oncology, Queen‘s University of Belfast, Global VP and Medical Director Almac Diagnostics
Prof. Dr. Fritz Aberger
Molecular Cancer and Stem Cell Research, Lab Department of Molecular Biology, University of Salzburg, Cancer Cluster Salzburg (CCS), Salzburg, Austria
Dr. Gabriel Rinnerthaler
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer, Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Marleen Kok MD PhD
Medical Oncologist and Research Fellow, Cancer Immunotherapy of the Dutch Cancer Society, The Netherlands Cancer Institute, Amsterdam, the Netherlands
Dr. Roberto Salgado
Department of Pathology, GZA-ZNA Antwerp, Belgium; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Australia
Priv.-Doz. Dr. Alexander Egle
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer, Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Marco Gerlinger MD FRCP
Medical Oncologist and Research Group Leader, Translational Oncogenomics Laboratory, Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom
Dr. Simon P. Gampenrieder
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Giuseppe Curigliano MD PhD
University of Milan, Director, New Drugs and Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy
Prof. Dr. Udo Gaipl (absent)
Head of Radiation Immunobiology, Universitätsklinikum Erlangen, Department of Radiation Oncology, Erlangen, Germany